Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Centene Corp. | 15 | 0 | 4 | 0 | €70.09 | €82.57 | 17.806% |
| G1 Therapeutics | 15 | 1 | 3 | 0 | €4.14 | €10.05 | 143.085% |
| Stoke Therapeutics Inc | 15 | 1 | 3 | 0 | €11.20 | €21.00 | 87.532% |
| Align Technology | 15 | 2 | 4 | 0 | €266.10 | €345.95 | 30.008% |
| Abbott Laboratories | 16 | 0 | 2 | 0 | €98.47 | €116.81 | 18.623% |
| Hologic Inc. | 16 | 0 | 4 | 0 | €71.00 | €83.99 | 18.301% |
| Agilent Technologies Inc. | 17 | 3 | 1 | 1 | €130.04 | €133.66 | 2.784% |
| Krystal Biotech | 17 | 0 | 4 | 0 | €145.00 | €179.60 | 23.859% |
| Cigna Corp. | 17 | 0 | 3 | 0 | €319.80 | €342.35 | 7.052% |
| Merit Medical Systems | 17 | 0 | 6 | 0 | €72.00 | €86.90 | 20.690% |
| Novo Nordisk A/S ADR | 17 | 1 | 1 | 0 | €118.00 | €130.00 | 10.169% |
| Natural Alternat. | 17 | 1 | 0 | 0 | €5.75 | - | - |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €40.00 | €84.74 | 111.860% |
| Icon plc | 18 | 0 | 3 | 0 | €294.70 | €319.67 | 8.473% |
| Dexcom Inc. | 18 | 0 | 2 | 0 | €120.36 | €136.82 | 13.677% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €20.35 | €26.01 | 27.796% |
| Sutro Biopharma Inc | 18 | 0 | 0 | 0 | €3.58 | €11.05 | 208.615% |
| United Therapeutics | 18 | 0 | 3 | 0 | €243.70 | €288.66 | 18.449% |
| R1 RCM Inc. | 19 | 0 | 1 | 0 | €11.80 | €17.21 | 45.869% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €12.88 | €25.20 | 95.674% |
| Resmed Inc. | 19 | 0 | 3 | 0 | €201.10 | €207.72 | 3.290% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €76.26 | €102.62 | 34.565% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €151.82 | €174.43 | 14.895% |
| Zoetis Inc. A | 22 | 1 | 4 | 0 | €155.08 | €198.11 | 27.748% |
| Trinity Biotech ADR | 22 | 0 | 1 | 0 | €0.41 | - | - |